125 related articles for article (PubMed ID: 9576009)
1. Selective response of CD5+ B cell malignancies to activation of the CD72 antigen.
Planken EV; Van de Velde H; Falkenburg JH; Thielemans K; Willemze R; Kluin-Nelemans JC
Clin Immunol Immunopathol; 1998 Apr; 87(1):42-9. PubMed ID: 9576009
[TBL] [Abstract][Full Text] [Related]
2. Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells.
Jamin C; Le Corre R; Pers JO; Dueymes M; Lydyard PM; Youinou P
Int Immunol; 1997 Jul; 9(7):1001-9. PubMed ID: 9237109
[TBL] [Abstract][Full Text] [Related]
3. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity.
Cerutti A; Trentin L; Zambello R; Sancetta R; Milani A; Tassinari C; Adami F; Agostini C; Semenzato G
J Immunol; 1996 Sep; 157(5):1854-62. PubMed ID: 8757302
[TBL] [Abstract][Full Text] [Related]
4. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
[TBL] [Abstract][Full Text] [Related]
5. Native soluble CD5 delivers a costimulatory signal to resting human B lymphocytes.
Van de Velde H; Thielemans K
Cell Immunol; 1996 Aug; 172(1):84-91. PubMed ID: 8806810
[TBL] [Abstract][Full Text] [Related]
6. Proliferation of B cell malignancies in all stages of differentiation upon stimulation in the 'CD40 system'.
Planken EV; Dijkstra NH; Willemze R; Kluin-Nelemans JC
Leukemia; 1996 Mar; 10(3):488-93. PubMed ID: 8642867
[TBL] [Abstract][Full Text] [Related]
7. A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5.
Bikah G; Lynd FM; Aruffo AA; Ledbetter JA; Bondada S
Int Immunol; 1998 Aug; 10(8):1185-96. PubMed ID: 9723705
[TBL] [Abstract][Full Text] [Related]
8. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
Van de Velde H; von Hoegen I; Luo W; Parnes JR; Thielemans K
Nature; 1991 Jun; 351(6328):662-5. PubMed ID: 1711157
[TBL] [Abstract][Full Text] [Related]
9. CD5- small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia.
Huang JC; Finn WG; Goolsby CL; Variakojis D; Peterson LC
Am J Clin Pathol; 1999 Jan; 111(1):123-30. PubMed ID: 9894463
[TBL] [Abstract][Full Text] [Related]
10. CD72 ligation regulates defective naive newborn B cell responses.
Howard LM; Reen DJ
Cell Immunol; 1997 Feb; 175(2):179-88. PubMed ID: 9023424
[TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct CD5- B cell subsets from human tonsils with different responses to CD40 monoclonal antibody.
Dono M; Zupo S; Masante R; Taborelli G; Chiorazzi N; Ferrarini M
Eur J Immunol; 1993 Apr; 23(4):873-81. PubMed ID: 7681401
[TBL] [Abstract][Full Text] [Related]
12. Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses.
Ishida I; Kumanogoh A; Suzuki K; Akahani S; Noda K; Kikutani H
Int Immunol; 2003 Aug; 15(8):1027-34. PubMed ID: 12882840
[TBL] [Abstract][Full Text] [Related]
13. CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case-control study.
Asmiyou A; Bakr AM; Shahin DA; Wahba Y
Lupus; 2020 Sep; 29(10):1270-1276. PubMed ID: 32700598
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
15. Selective internalization of monoclonal antibodies by B-cell chronic lymphocytic leukaemia cells.
Sieber T; Schoeler D; Ringel F; Pascu M; Schriever F
Br J Haematol; 2003 May; 121(3):458-61. PubMed ID: 12716368
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of B lymphocytes via CD72 (human Lyb-2).
Kamal M; Katira A; Gordon J
Eur J Immunol; 1991 Jun; 21(6):1419-24. PubMed ID: 1828426
[TBL] [Abstract][Full Text] [Related]
17. Interaction of CD5 and CD72 is involved in regulatory T and B cell homeostasis.
Zheng M; Xing C; Xiao H; Ma N; Wang X; Han G; Chen G; Hou C; Shen B; Li Y; Wang R
Immunol Invest; 2014; 43(7):705-16. PubMed ID: 24950378
[TBL] [Abstract][Full Text] [Related]
18. CD5+, CD11C+, trap-positive chronic lymphocytic leukemia/prolymphocytic leukemia.
Prince HM; Bashford J; van der Weyden MB
Blood; 1992 Aug; 80(4):1095-6. PubMed ID: 1379851
[No Abstract] [Full Text] [Related]
19. Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.
Katira A; Kamal M; Gordon J
Immunology; 1992 Jul; 76(3):422-6. PubMed ID: 1388135
[TBL] [Abstract][Full Text] [Related]
20. In vitro activation of leukaemic B cells by interleukin-4 and antibodies to CD40.
Crawford DH; Catovsky D
Immunology; 1993 Sep; 80(1):40-4. PubMed ID: 7503945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
